REPLACE: (Riociguat rEplacing PDE5i therapy evaluated Against Continued PDE5i therapy): A Look at Phase IV Study Data

This live web event has ended. Thank you for attending.

Ioana Preston, MD

Pulmonary Function Lab Director; Director, Pulmonary Hypertension Center;
Associate Professor, Tufts University School of Medicine

Prescribing Information
http://labeling.bayerhealthcare.com/html/products/pi/Adempas_PI.pdf

September 1, 2021

Wed 6:30 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support

(888) 705-6002

+1 (858) 201-4136*

*for callers residing outside of the United States